AI-driven drug safety databases are transforming pharmacovigilance with automation, real-time insights, and predictive analytics—enhancing patient safety, regulatory compliance, and operational efficiency.

Standardized drug safety databases enhance pharmacovigilance by improving data quality, enabling faster signal detection, and ensuring global compliance, ultimately protecting patient safety and public health.

AI and automation transform drug safety literature reviews by increasing efficiency, accuracy, and compliance—helping pharmacovigilance teams detect risks faster and protect patients better.